Glutathione and Improved Liver Function (AST)

Time to effect

Median: 3 months · IQR 3 months–3 months · Range 3 months–3 months — Reported in 1 of 1 study

Safety in these studies

headacheNo significant difference
Adverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA cleara
mild gastric discomfortNo significant difference
Adverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA cleara
nauseaNo significant difference
Adverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA cleara
vomitingNo significant difference
Adverse reaction rates were 8.89% in the observation group and 20.00% in the control group (P > 0.05).
from: Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA cleara

1 of 1 paper

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients.